Ausgabe 1/2023
Inhalt (10 Artikel)
Comparison of two immunohistochemical staining protocols for ALK demonstrates non-inferiority of a 5A4 clone-based protocol versus an ALK01 clone-based protocol for the diagnosis of ALK + anaplastic large cell lymphoma
Sebastian Fernandez-Pol, Cristiane R. Ferreira, Vidhya Manohar, José Antonio Sanches, Luis A. P. C. Lage, Juliana Pereira, Maria C. N. Zerbini, Dita Gratzinger, Yasodha Natkunam
PD-L1 immunohistochemistry assay optimization to provide more comprehensive pathological information in classic Hodgkin lymphoma
Yunfei Shi, Lan Mi, Yumei Lai, Min Zhao, Ling Jia, Tingting Du, Yuqin Song, Xianghong Li
Flow cytometric measurable residual disease in adult acute myeloid leukemia: a preliminary report from Eastern India
Neha Singh, Avinash Gupta, Sujeet Kumar, Gojiri Mawalankar, Bhumika Gupta, Nilesh Dhole, RohitKumar Kori, Anil Singh
A case of clinically aggressive EBV-negative ENKTL in a non-Asian female patient
Thomas Kent, Gregory Scott, Robert Seifert
Acute mast cell leukemia without KIT D816V mutation and lack of CD2 and CD25—a case report of rare entity
Eliza Zaremba-Pataj, Elżbieta Patkowska, Agnieszka Krzywdzińska, Anna Szumera-Ciećkiewicz, Justyna Chlebowska-Tuz
Mixed-phenotype acute leukemia, T/megakaryoblastic: does it really exist?
Neelum Mansoor, Omer Javed, Naila Rafiq, Anila Aali, Fatima Meraj
TRBC1 enables identification of an otherwise immunophenotypically silent case of angioimmunoblastic T-cell lymphoma
Jingjing Zhang, Sebastian Fernandez-Pol